AMICUS THERAPEUTICS, INC. Quarterly Interest Expense in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Amicus Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q1 2024.
  • Amicus Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $12.4M, a 5% increase year-over-year.
  • Amicus Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $50.7M, a 24.3% increase year-over-year.
  • Amicus Therapeutics, Inc. annual Interest Expense for 2023 was $50.1M, a 35.1% increase from 2022.
  • Amicus Therapeutics, Inc. annual Interest Expense for 2022 was $37.1M, a 14.3% increase from 2021.
  • Amicus Therapeutics, Inc. annual Interest Expense for 2021 was $32.5M, a 44.8% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $50.7M $12.4M +$592K +5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $50.1M $12.8M +$1.73M +15.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $48.4M $13M +$3.37M +35% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $45.1M $12.5M +$4.24M +51.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $40.8M $11.8M +$3.7M +45.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $37.1M $11.1M +$2.93M +35.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $34.2M $9.62M +$1.46M +17.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $32.7M $8.26M +$107K +1.31% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $32.6M $8.15M +$155K +1.94% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $32.5M $8.16M -$113K -1.37% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $32.6M $8.17M +$1.38M +20.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $31.2M $8.15M +$4.52M +124% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $26.7M $7.99M +$4.26M +114% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $22.4M $8.28M +$4.51M +120% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $17.9M $6.78M +$2.76M +68.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $15.2M $3.64M -$990K -21.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $16.1M $3.73M -$2.73M -42.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $18.9M $3.77M -$4.87M -56.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $23.7M $4.03M -$689K -14.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $24.4M $4.63M +$65K +1.43% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $24.4M $6.45M +$1.97M +43.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $22.4M $8.64M +$4.22M +95.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $18.2M $4.72M +$364K +8.37% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $17.8M $4.56M +$381K +9.12% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $17.4M $4.49M +$198K +4.62% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $17.2M $4.42M +$2.54M +135% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $14.7M $4.35M +$2.83M +187% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $11.9M $4.18M +$3.12M +296% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $8.74M $4.29M +$3.35M +354% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $5.4M $1.88M +$1.03M +121% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $4.37M $1.52M +$1.5M +8824% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $2.87M $1.06M +$717K +212% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $2.15M $945K +$573K +154% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $1.58M $851K +$473K +125% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $1.11M $17K -$360K -95.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $1.47M $338K -$36K -9.63% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $1.5M $372K +$17K +4.79% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $1.48M $378K +$358K +1790% Oct 1, 2014 Dec 31, 2014 10-K/A 2017-03-03
Q3 2014 $1.13M $377K +$370K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $756K $374K +$365K +4056% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $391K $355K +$345K +3450% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $46K $20K +$8K +66.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $38K $7K* -$12K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $50K $9K -$6K -40% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $56K $10K -$33K -76.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 $89K $12K -$15K -55.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-03
Q3 2012 $104K $19K -$13K -40.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $117K $15K -$26K -63.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $143K $43K -$5K -10.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $148K $27K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 $32K -$34K -51.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $41K -$14K -25.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $48K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 $66K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-02
Q2 2010 $55K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.